CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,809,219 | -26.3% | 77,434 | -0.6% | 0.09% | -18.9% |
| Q2 2023 | $10,589,229 | +131361.6% | 77,925 | +0.5% | 0.11% | +27.6% |
| Q1 2023 | $8,055 | -28.3% | 77,564 | -38.8% | 0.09% | -30.4% |
| Q4 2022 | $11,230 | -99.9% | 126,693 | +7.2% | 0.12% | +10.6% |
| Q3 2022 | $9,477,000 | -1.7% | 118,214 | +17.4% | 0.11% | +3.7% |
| Q2 2022 | $9,642,000 | -8.3% | 100,672 | +42.3% | 0.11% | +7.9% |
| Q1 2022 | $10,512,000 | +5.0% | 70,762 | +0.2% | 0.10% | +9.8% |
| Q4 2021 | $10,008,000 | -43.1% | 70,593 | -47.5% | 0.09% | +8.2% |
| Q3 2021 | $17,602,000 | +95.7% | 134,532 | +105.5% | 0.08% | -2.3% |
| Q2 2021 | $8,995,000 | +11.5% | 65,454 | +5.9% | 0.09% | +8.8% |
| Q1 2021 | $8,069,000 | +15.4% | 61,788 | -1.1% | 0.08% | +2.6% |
| Q4 2020 | $6,995,000 | +39.8% | 62,462 | -1.8% | 0.08% | +14.7% |
| Q3 2020 | $5,004,000 | +486.6% | 63,596 | +436.3% | 0.07% | +385.7% |
| Q2 2020 | $853,000 | +129.3% | 11,858 | +82.5% | 0.01% | +75.0% |
| Q1 2020 | $372,000 | – | 6,496 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |